Mark B. Hamner

7.7k total citations
89 papers, 4.1k citations indexed

About

Mark B. Hamner is a scholar working on Clinical Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Mark B. Hamner has authored 89 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Clinical Psychology, 30 papers in Psychiatry and Mental health and 27 papers in Pharmacology. Recurrent topics in Mark B. Hamner's work include Posttraumatic Stress Disorder Research (40 papers), Treatment of Major Depression (24 papers) and Anesthesia and Neurotoxicity Research (11 papers). Mark B. Hamner is often cited by papers focused on Posttraumatic Stress Disorder Research (40 papers), Treatment of Major Depression (24 papers) and Anesthesia and Neurotoxicity Research (11 papers). Mark B. Hamner collaborates with scholars based in United States, Switzerland and United Kingdom. Mark B. Hamner's co-authors include B. Christopher Frueh, George W. Arana, Jeffrey P. Lorberbaum, Paul B. Gold, Mark S. George, Anouk L. Grubaugh, Helen G. Ulmer, Michael David Horner, Rebecca G. Knapp and Lawrence A. Labbate and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Mark B. Hamner

86 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark B. Hamner United States 35 2.4k 956 632 607 554 89 4.1k
Larry A. Tupler United States 34 1.8k 0.8× 946 1.0× 468 0.7× 646 1.1× 651 1.2× 73 4.4k
Teri Pearlstein United States 44 2.9k 1.2× 740 0.8× 577 0.9× 448 0.7× 492 0.9× 88 6.1k
Guillaume Vaïva France 31 1.7k 0.7× 1.0k 1.1× 415 0.7× 233 0.4× 448 0.8× 208 3.5k
Miles McFall United States 37 3.4k 1.4× 373 0.4× 365 0.6× 557 0.9× 747 1.3× 84 5.2k
Tuvia Peri Israel 23 2.8k 1.2× 438 0.5× 196 0.3× 552 0.9× 546 1.0× 52 4.1k
Margaret T. Davis United States 19 3.1k 1.3× 458 0.5× 309 0.5× 515 0.8× 454 0.8× 49 4.7k
Gil Zalsman Israel 36 3.3k 1.4× 1.7k 1.8× 567 0.9× 282 0.5× 566 1.0× 212 5.7k
Patricia B. Sutker United States 40 3.3k 1.4× 892 0.9× 265 0.4× 1.3k 2.1× 562 1.0× 136 5.6k
D. Jeffrey Newport United States 43 3.2k 1.3× 1.4k 1.5× 626 1.0× 436 0.7× 608 1.1× 118 8.8k
John Kasckow United States 33 1.1k 0.5× 1.1k 1.2× 374 0.6× 198 0.3× 405 0.7× 105 3.8k

Countries citing papers authored by Mark B. Hamner

Since Specialization
Citations

This map shows the geographic impact of Mark B. Hamner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Hamner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Hamner more than expected).

Fields of papers citing papers by Mark B. Hamner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Hamner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Hamner. The network helps show where Mark B. Hamner may publish in the future.

Co-authorship network of co-authors of Mark B. Hamner

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Hamner. A scholar is included among the top collaborators of Mark B. Hamner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Hamner. Mark B. Hamner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villarreal, Gerardo, Mark B. Hamner, Clifford Qualls, & José M. Cañive. (2025). Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder. Psychopharmacology Bulletin. 48(2). 8–17.
2.
3.
Richman, Joshua, Thaddeus W. W. Pace, Kelvin O. Lim, et al.. (2022). Biomarker Response to Mindfulness Intervention in Veterans Diagnosed with Post-traumatic Stress Disorder. Mindfulness. 13(10). 2448–2460. 8 indexed citations
4.
Nietert, Paul J., et al.. (2021). Dopamine transporter (DAT1) gene in combat veterans with PTSD: A case-control study. Psychiatry Research. 298. 113801–113801. 7 indexed citations
5.
Tuerk, Peter W., Bethany C. Wangelin, Mark B. Powers, et al.. (2018). Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cognitive Behaviour Therapy. 47(5). 351–371. 52 indexed citations
6.
Hamner, Mark B., et al.. (2018). Posttraumatic stress disorder with secondary psychotic features (PTSD-SP): Diagnostic and treatment challenges. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 88. 265–275. 72 indexed citations
7.
Adams, Zachary W., et al.. (2017). Cue-dependent inhibition in posttraumatic stress disorder and attention-deficit/hyperactivity disorder. Journal of Anxiety Disorders. 51. 1–6. 4 indexed citations
8.
Rasmusson, Ann M., Christine E. Marx, Sonia Jain, et al.. (2017). A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology. 234(15). 2245–2257. 45 indexed citations
9.
Short, E. Baron, et al.. (2016). Pyrotherapy for the Treatment of Psychosis in the 21st Century: A Case Report and Literature Review. Journal of Psychiatric Practice. 22(5). 410–415. 7 indexed citations
10.
Barkin, Robert L., et al.. (2012). Schizophrenia: Improving the Continuity of Care to Ensure Optimal Patient Outcomes. Disease-a-Month. 58(7). 395–409. 1 indexed citations
11.
Tuerk, Peter W., Matthew Yoder, Anouk L. Grubaugh, et al.. (2010). Prolonged exposure therapy for combat-related posttraumatic stress disorder: An examination of treatment effectiveness for veterans of the wars in Afghanistan and Iraq. Journal of Anxiety Disorders. 25(3). 397–403. 156 indexed citations
12.
Robert, Sophie, et al.. (2006). Open-Label Trial of Escitalopram in the Treatment of Posttraumatic Stress Disorder. The Journal of Clinical Psychiatry. 67(10). 1522–1526. 35 indexed citations
13.
Hamner, Mark B. & Sophie Robert. (2005). Emerging roles for atypical antipsychotics in chronic post-traumatic stress disorder. Expert Review of Neurotherapeutics. 5(2). 267–275. 18 indexed citations
14.
Magruder, Kathryn M., B. Christopher Frueh, Rebecca G. Knapp, et al.. (2005). Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics. General Hospital Psychiatry. 27(3). 169–179. 225 indexed citations
15.
Frueh, B. Christopher, Jon D. Elhai, Anouk L. Grubaugh, et al.. (2005). Documented combat exposure of US veterans seeking treatment for combat-related post-traumatic stress disorder. The British Journal of Psychiatry. 186(6). 467–472. 120 indexed citations
16.
Hamner, Mark B., Sophie Robert, & B. Christopher Frueh. (2004). Treatment-Resistant Posttraumatic Stress Disorder: Strategies for Intervention. CNS Spectrums. 9(10). 740–752. 81 indexed citations
17.
Hamner, Mark B., et al.. (2003). Quetiapine Treatment in Patients with Posttraumatic Stress Disorder: An Open Trial of Adjunctive Therapy. Journal of Clinical Psychopharmacology. 23(1). 15–20. 97 indexed citations
18.
Hamner, Mark B.. (2002). The effects of atypical antipsychotics on serum prolactin levels.. Annals of Clinical Psychiatry. 14(3). 163–173. 53 indexed citations
19.
Frueh, B. Christopher, Paul B. Gold, Karen L. Pellegrin, et al.. (2000). Differentiation of depression and PTSD symptoms in combat veterans. Depression and Anxiety. 11(4). 175–179. 6 indexed citations
20.
Hamner, Mark B.. (1998). Recurrent Psychotic Depression Associated With GM2 Gangliosidosis. Psychosomatics. 39(5). 446–448. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larry A. Tupler Breakdown of academic impact, for papers by Teri Pearlstein Breakdown of academic impact, for papers by Guillaume Vaïva Breakdown of academic impact, for papers by Miles McFall Breakdown of academic impact, for papers by Tuvia Peri Breakdown of academic impact, for papers by Margaret T. Davis Breakdown of academic impact, for papers by Gil Zalsman Breakdown of academic impact, for papers by Patricia B. Sutker Breakdown of academic impact, for papers by D. Jeffrey Newport Breakdown of academic impact, for papers by John Kasckow
Rankless by CCL
2026